What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
.
Singh R, et al. Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1481-1485. doi: 10.1007/s10096-020-03862-3. Epub 2020 Mar 20. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32193689